Norepinephrine-induced changes in gene expression of phospholipase C in cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 1, 2006, Pages 126-137

  Singal, Tushi ^a   Dhalla, Naranjan S ^a   Tappia, Paramjit S ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

1 adrenoceptors; Adult cardiomyocytes; Cardiac gene expression; Extracellular signal regulated kinase; Phospholipase isozymes; Protein kinase C; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BISINDOLYLMALEIMIDE; ISOENZYME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C BETA1; PHOSPHOLIPASE C BETA3; PHOSPHOLIPASE C DELTA1; PHOSPHOLIPASE C GAMMA1; PHOSPHOLIPASE C INHIBITOR; PRAZOSIN; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; CELL SIZE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRENES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; MALE; MYOCYTES, CARDIAC; NOREPINEPHRINE; PHOSPHOLIPASE C; PRAZOSIN; PROTEIN KINASE C; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 33745656994     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.03.004     Document Type: Article

References (37)

1. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70 (2001) 281-312
2. Sabri A., and Steinberg S.F. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol. Cell. Biochem. 251 (2003) 97-101
3. 2+, diacylglycerol, and protein kinase C signaling using fluorescent biosensors. J. Biol. Chem. 280 (2005) 21837-21846
4. 1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33 (2001) 779-787
5. Kawaguchi H., Sano H., Iizuka K., Okada H., Kudo T., Kageyama K., et al. Phosphatidylinositol metabolism in hypertrophic rat heart. Circ. Res. 72 (1993) 966-972
6. 1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy. Hokkaido Igaku Zasshi 68 (1993) 18-28
7. Ruwhof C., van Wamel J.T., Noordzij L.A., Aydin S., Harper J.C., and van der Laarse A. Mechanical stress stimulates phospholipase C activity and intracellular calcium ion levels in neonatal rat cardiomyocytes. Cell Calcium 29 (2001) 73-83
8. Lamers J.M., Eskildsen-Helmond Y.E., Resink A.M., de Jonge H.W., Bezstarosti K., Sharma H.S., et al. Endothelin-1-induced phospholipase C-β and D and protein kinase C isoenzyme signaling leading to hypertrophy in rat cardiomyocytes. J. Cardiovasc. Pharmacol. 26 (1995) S100-S103
9. 1-adrenoceptor subtypes: functions and signaling. Can. J. Physiol. Pharm. 78 (2000) 267-292
10. Scheuer J. Catecholamines in cardiac hypertrophy. Am. J. Cardiol. 83 (1999) 70H-74H
11. Schnabel P., Mies F., Nohr T., Geisler M., and Bohm M. Differential regulation of phospholipase C-β isozymes in cardiomyocyte hypertrophy. Biochem. Biophys. Res. Commun. 275 (2000) 1-6
12. Singal T., Dhalla N.S., and Tappia P.S. Phospholipase C may be involved in norepinephrine-induced cardiac hypertrophy. Biochem. Biophys. Res. Commun. 320 (2004) 1015-1019
13. Tappia P.S., Liu S.Y., Shatadal S., Takeda N., Dhalla N.S., and Panagia V. Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril. Am. J. Physiol. 277 (1999) H40-H49
14. Liu S.Y., Yu C.H., Hays J.A., Panagia V., and Dhalla N.S. Modification of heart sarcolemmal phosphoinositide pathway by lysophosphatidylcholine. Biochim. Biophys. Acta 1349 (1997) 264-274
15. 1 in rat neonatal cardiomyocytes. J. Biol. Chem. 276 (2001) 37341-37346
16. Giles T.D., Sander G.E., Thomas M.G., and Quiroz A.C. α-adrenergic mechanisms in the pathophysiology of left ventricular heart failure-An analysis of their role in systolic and diastolic dysfunction. J. Mol. Cell. Cardiol. 18 (1986) 33-43
17. Strauer B.E., Bayer F., Brecht H.M., and Motz W. The influence of sympathetic nervous activity on regression of cardiac hypertrophy. J. Hypertens., Suppl. 3 (1985) S39-S44
18. Prasad K., O'Neil C.L., and Bharadwaj B. Effect of prolonged prazosin treatment on hemodynamic and biochemical changes in the dog heart due to chronic pressure overload. Jpn. Heart J. 25 (1984) 461-476
19. Motz W., Klepzig M., and Strauer B.E. Regression of cardiac hypertrophy: experimental and clinical results. J. Cardiovasc. Pharmacol. 10 (1987) S148-S152
20. Strauer B.E. Progression and regression of heart hypertrophy in arterial hypertension: pathophysiology and clinical aspects. Z. Kardiol. 74 (1985) 171-178
21. Strauer B.E. Regression of myocardial and coronary vascular hypertrophy in hypertensive heart disease. J. Cardiovasc. Pharmacol. 12 (1988) S45-S54
22. Hepler J.R., Kozasa T., Smrcka A.V., Simon M.I., Rhee S.G., Sternweis P.C., et al. Purification from Sf9 cells and characterization of recombinant Gqα and G11α. Activation of purified phospholipase C isozymes by Gα subunits. J. Biol. Chem. 268 (1993) 14367-14375
23. 3. J. Biol. Chem. 268 (1993) 6654-6661
24. Minamino T., Yujiri T., Terada N., Taffet G.E., Michael L.H., Johnson G.L., et al. MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3866-3871
25. 1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc. Res. 51 (2001) 709-716
26. Tappia P.S., Padua R.R., Panagia V., and Kardami E. Fibroblast growth factor-2 stimulates phospholipase C β in adult cardiomyocytes. Biochem. Cell. Biol. 77 (1999) 569-575
27. Nakaoka H., Perez D.M., Baek K.J., Das T., Husain A., Misono K., et al. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264 (1994) 1593-1596
28. Braz J.C., Bueno O.F., De Windt L.J., and Molkentin J.D. PKC α regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J. Cell Biol. 156 (2002) 905-919
29. Takeishi Y., Ping P., Bolli R., Kirkpatrick D.L., Hoit B.D., and Walsh R.A. Transgenic overexpression of constitutively active protein kinase C ε causes concentric cardiac hypertrophy. Circ. Res. 86 (2000) 1218-1223
30. Martelli A.M., Capitani S., and Neri L.M. The generation of lipid signaling molecules in the nucleus. Prog. Lipid Res. 38 (1999) 273-308
31. 1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol. Pharmacol. 51 (1997) 764-775
32. Bai H., Wu L.L., Xing D.Q., Liu J., and Zhao Y.L. Angiotensin II induced upregulation of G αq/11, phospholipase C β3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor. Chin. Med. J. (Engl) 117 (2004) 88-93
33. Xu Y., Hopfner R.L., McNeill J.R., and Gopalakrishnan V. Vasopressin accelerates protein synthesis in neonatal rat cardiomyocytes. Mol. Cell. Biochem. 195 (1999) 183-190
34. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273 (1998) 1839-1842
35. Hawes B.E., van Biesen T., Koch W.J., Luttrell L.M., and Lefkowitz R.J. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270 (1995) 17148-17153
36. Khorchid A., Larocca J.N., and Almazan G. Characterization of the signal transduction pathways mediating noradrenaline-stimulated MAPK activation and c-fos expression in oligodendrocyte progenitors. J. Neurosci. Res. 58 (1999) 765-778
37. Barac Y.D., Zeevi-Levin N., Yaniv G., Reiter I., Milman F., Shilkrut M., et al. The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovasc. Res. 68 (2005) 75-86